Barely Significant
← all phrases

“a decreasing trend”

47,181 sentences · 47,181 papers · 78,848 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

87,195,196 Intense studies on the Ti–Ni system revealed a decreasing trend for HER activity in the order TiNi 2 > TiNi 3 > TiNi 4 > Ti 2 Ni > TiNi > Ti 3 Ni > TiNi 0.7 in which only TiNi 3 exhibited the highest activity. 197 The Raney nickel system with Ni 3 Al as analogous to TiAl with a similar face-centered cubic unit cell as well as structural order has also been investigated as the catalyst material for HER. 198 Early reported phase pure Ni 2 Al 3 and NiAl 3 with minor impurities of Ni 2 Al 3 were tested in 1 M KOH for HER activity and demonstrated good activity and stability.
Our previous meta‐analysis approach showed a decreasing trend of drug clearance as CKD severity increases for CYP2C8 substrate drugs; however, the data were inconclusive due to the overlapping substrate specificity with OATP1B. 13 The present PBPK analysis suggests a negligible change in CYP2C8 function/activity in patients with severe CKD.
In the late fermentation stage, the alcohol content showed a decreasing trend, which was possibly due to the inhibited yeast growth under the poor environment following the acid-producing period; subsequently, a portion of the alcohol was converted into acids and esters ( Richter et al., 2013 ).
As for the SARs for the complications of T2DM, most regions showed a decreasing trend for each of the complications except for SAR of T2DM with CKD in Region 9 that increased from 0.86 to 1.05 in the same period; MI in Region 7 that increased from 0.88 in 2009 to 1.01 in 2016; cerebrovascular diseases that increased in Regions 7 and 9 between 2009 and 2016, from 0.83 to 1.03 and 0.65 to 1.11, respectively; retinopathy that increased in Regions 8 and 11 (Surat Thani) from 0.43 to 1.11 and 0.52 to 1.00, respectively; foot amputation that in northeastern regions of Regions 7 and 8 that increased from 1.35 to 1.61 and 1.24 to 1.43, respectively.
A decreasing trend in mean reported pain level from 1.2 to 0.8 (on a 0–10 integer scale) over the course of four injections was observed in patients who injected themselves once weekly with a placebo‐filled dulaglutide pen‐injector. 6 However, it is plausible that a similar decrement would apply to semaglutide.